Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma
about
A Novel Prognostic Scoring System Using Inflammatory Response Biomarkers for Esophageal Squamous Cell Carcinoma.PAP/REG3A favors perineural invasion in pancreatic adenocarcinoma and serves as a prognostic marker.Pancreatic adenocarcinoma, chronic pancreatitis, and MODY-8 diabetes: is bile salt-dependent lipase (or carboxyl ester lipase) at the crossroads of pancreatic pathologies?Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities.
P2860
Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma
@ast
Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma
@en
Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma
@nl
type
label
Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma
@ast
Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma
@en
Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma
@nl
prefLabel
Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma
@ast
Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma
@en
Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma
@nl
P2860
P921
P3181
P356
P1476
Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma
@en
P2093
Shiro Kimbara
Shunsuke Kondo
P2860
P304
P3181
P356
10.3748/WJG.V22.I33.7440
P407
P5008
P577
2016-09-07T00:00:00Z